EMVS connection provider

OPTEL GROUP Approved As Technically Certified Connection Provider By EMVO

Enhancements to serialization and traceability software will better prepare European pharma for EU FM compliance.

OPTEL GROUP successfully passed European Medicines Verification Systems (EMVS) certification for version 1.3 and has been registered as a Technically Certified Connection Provider by the European Medicines Verification Organization (EMVO).  In addition, OPTEL GROUP has announced Verify Brand® Software platform enhancements in preparation for European Falsified Medicines Directive (FMD).

EMVO Certification Approval

EU FMD states as of February 9, 2019, Marketing Authorization Holders (MAHs) that distribute pharmaceutical drugs under the FMD will be required send serialization data to the EU Hub via EMVS. As a Technically Certified Connection Provider, OPTEL GROUP can support its European customers by connecting and transferring information securely to the EU Hub.

“Becoming officially certified on the latest version of the EMVS is an important benchmark in providing our European customers with seamless support for EU FMD compliance,” said Louis Roy, CEO at OPTEL GROUP. “We are committed to maintaining our certification as future versions of the EMVS are released, and we look forward to continue growing our large client base in Europe.”

Verify Brand® Software Update

Recent updates to OPTEL’s Verify Brand Software platform improve existing communications for EU FMD compliance, including a closer alignment with the FMD master data requirements. Additional features include enhancements in technical capabilities, features and functionality to ensure our customers meet regulatory compliance while also gaining supply chain visibility and value-added supply chain analytics and insights.

To learn more about OPTEL GROUP, please contact us here: https://www.optelgroup.com/contact/


Translate »